Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor

Details for Australian Patent Application No. 2011202479 (hide)

Owner Genentech, Inc.

Inventors Derynck, Mika K.; Kelsey, Stephen M.

Agent Griffith Hack

Pub. Number AU-A-2011202479

Parent 2006216732

Filing date 26 May 2011

Wipo publication date 23 June 2011

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 June 2011 Complete Application Filed

23 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202479

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202480-A gaming system and a method of gaming

2011202478-A gaming system and a method of gaming